Company news
Aligos Therapeutics, Inc. news in 2020
Aligos Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH
December 6, 2020
Aligos Therapeutics Presents Data on Chronic Hepatitis B, NASH and Hepatocellular Carcinoma Programs at AASLD’s The Liver Meeting Digital Experience™ 2020
November 15, 2020
Aligos Therapeutics Announces Presentations at the Jefferies Virtual London Healthcare Conference & the Piper Sandler Annual Healthcare Conference
November 12, 2020
Aligos Therapeutics is awarded €1.8M VLAIO grant to advance chronic hepatitis B research
November 11, 2020
Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B
October 29, 2020
Aligos Therapeutics Announces Pricing of Initial Public Offering
October 14, 2020
Decks in 2020
- Jefferies Healthcare Conference 2020
Conference · 33 slides · Jun 4, 2020